Navigation Links
More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch

MONROVIA, Calif., April 23 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced very strong participation in the first of its nine-part webinar series on the Company's Visian ICL(TM) (Implantable Collamer Lens). The first session which aired Tuesday, April 22, 2008, titled "How My Website Compels Patients to Call Me," is part of a new marketing initiative designed to help refractive physicians build their Visian ICL practices. Over 450 physicians and more than 250 practice administrators registered for the ICL Growth Program.

The ICL Growth Program, developed in collaboration with Dr. Brian Boxer Wachler, focuses on the key elements required to build a successful Visian ICL practice. Dr. Boxer Wachler has developed a thriving Visian ICL practice and was recently featured on the NBC News Today show performing bilateral implants of the Visian ICL in his office suite. In addition, the work of other Visian ICL surgeons has been featured on numerous shows recently, including Dr. Steven Chang on ABC News in San Francisco, Dr. Konrad Filutowski on Fox News in Orlando and Dr. William Goldstein on Fox News in Detroit, while Dr. Paul Dougherty will be featured on an episode of the "Modern Beauty Show" airing on the Style Channel in three parts this month.

"We are pleased and excited that so many physicians and practice administrators took advantage of this program," said Barry G. Caldwell, President and CEO of STAAR. "Our ICL Growth Program is designed to help interested surgeons capitalize on the growing consumer awareness of the Visian ICL's benefits and complements our recent growth curve in the U.S. market. Dr. Boxer Wachler has made the Visian ICL an integral part of his successful practice, and we are delighted to have him share his story with other physicians. In future sessions of this nine part series other successful surgeons may be joining Dr. Boxer Wachler to share their experiences."

About STAAR Surgical

STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More information is available at

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including any statements of the plans, strategies, and objectives of management for future operations, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include our limited capital resources and limited access to financing, the challenge of managing foreign subsidiaries, the willingness of surgeons and patients to adopt a new product and procedure and other factors beyond our control, including those detailed from time to time in our reports filed with the Securities and Exchange Commission. STAAR assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes and does not intend to do so.

Contacts: Investors Media

EVC Group EVC Group

Doug Sherk, 415-896-6820 Steve DiMattia, 646-277-8706

Matthew Selinger, 415-896-6817 Chris Gale, 646-201-5431

SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
2. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
3. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
4. Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California
5. Physicians Reference Laboratory Announces New Diagnostic for Womens Health
6. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Hot Information for Physicians Treating Vasomotor Symptoms During the Menopausal Transition
9. Off-Label Stent Use: How Important Are FDA Approvals to Physicians?
10. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):